Reliance Industries Limited (RIL), led by Mukesh Ambani, has completed its acquisition of Karkinos Healthcare for ₹375 crore. This acquisition marks a significant step for RIL, which had previously acquired a minority stake in Karkinos in 2021. The deal, executed through Reliance Strategic Business Ventures Limited (RSBVL), includes a subscription to ₹375 crore worth of equity and optionally fully convertible debentures, making Karkinos a step-down wholly owned subsidiary of RIL. The announcement was made on December 28, 2024, and reflects Reliance's ongoing strategy of expansion through acquisitions, having invested approximately $13 billion in similar ventures over the past five years. As of December 30, 2024, Reliance's share price was reported at ₹1221.65, showing a slight uptick amidst market fluctuations.
Over the past five years, Reliance has spent $13 billion in acquisitions. Image via Morgan Stanley: https://t.co/GIHPaprEFR
𝐑𝐞𝐥𝐢𝐚𝐧𝐜𝐞 𝐈𝐧𝐝𝐮𝐬𝐭𝐫𝐢𝐞𝐬 𝐒𝐡𝐚𝐫𝐞 𝐏𝐫𝐢𝐜𝐞 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬: ₹𝟏𝟐𝟐𝟏.𝟔𝟓 𝐑𝐞𝐜𝐨𝐫𝐝𝐬 𝟎.𝟎𝟒𝟗𝟏% 𝐔𝐩𝐭𝐢𝐜𝐤' Reliance Industries' share price shows a slight uptick of 0.0491%, trading at ₹1221.65 as of December 30, 2024. The stock has demonstrated… https://t.co/9u7LXyaq1h
#RIL buys #KarkinosHealth for Rs 375 #crore https://t.co/k1DsOYhi3c